Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel

Mahesh Tambe(University of Helsinki), Marko J. Kallio(University of Turku)
Oncotarget
March 2, 2016
Cited by 39


Related Papers